Bill > HR2075

This bill, known as the Protecting Life and Integrity in Research Act of 2025, seeks to prohibit federal government agencies from conducting, funding, approving, or supporting research involving human fetal tissue obtained through induced abortions. The legislation allows for research using human fetal tissue obtained from miscarriages or stillbirths, with specific definitions provided for these terms. The bill modifies existing law to strictly limit fetal tissue research, permitting only tissue obtained from unintentional pregnancy losses. It also prohibits the solicitation or knowing acquisition of fetal tissue that was obtained through an induced abortion, including tissue from pregnancies deliberately initiated to provide such tissue. The bill maintains an exception for developing new cell lines for vaccine production and genetic vectors, provided these lines are not derived from aborted fetal tissue. Additionally, the legislation amends the Public Health Service Act to update definitions and restrictions around fetal tissue research, emphasizing that only tissue from miscarriages or stillbirths can be used in federally supported research, with specific criteria defining miscarriage (less than 20 weeks) and stillbirth (20 weeks or more).

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/2075/all-info